Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes
Authors
Keywords
-
Journal
JOURNAL OF HYPERTENSION
Volume 30, Issue 1, Pages 87-96
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-12-03
DOI
10.1097/hjh.0b013e32834dde5f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial Cell–Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II–Induced Ascending Aortic Aneurysms in LDL Receptor −/− Mice
- (2011) Debra L. Rateri et al. CIRCULATION RESEARCH
- A Resveratrol and Polyphenol Preparation Suppresses Oxidative and Inflammatory Stress Response to a High-Fat, High-Carbohydrate Meal
- (2011) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The gut microbiome as therapeutic target
- (2011) Patrice D. Cani et al. PHARMACOLOGY & THERAPEUTICS
- Differential Effect of Telmisartan and Amlodipine on Monocyte Chemoattractant Protein-1 and Peroxisome Proliferator-Activated Receptor-Gamma Gene Expression in Peripheral Monocytes in Patients With Essential Hypertension
- (2010) Maria E. Marketou et al. AMERICAN JOURNAL OF CARDIOLOGY
- Nutrient Modification of the Innate Immune Response
- (2010) Eric A. Schwartz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Losartan inhibits LPS-induced inflammatory signaling through a PPARγ-dependent mechanism in human THP-1 macrophages
- (2010) Jianbo An et al. HYPERTENSION RESEARCH
- Inflammation in neurodegenerative diseases
- (2010) Sandra Amor et al. IMMUNOLOGY
- Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
- (2010) Julius Benicky et al. NEUROPSYCHOPHARMACOLOGY
- PPAR Modulation of Kinase-Linked Receptor Signaling in Physiology and Disease
- (2010) Nicolas Rotman et al. PHYSIOLOGY
- Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications
- (2010) Juan M. Saavedra et al. PSYCHONEUROENDOCRINOLOGY
- Key Role of CD36 in Toll-Like Receptor 2 Signaling in Cerebral Ischemia
- (2010) Takato Abe et al. STROKE
- In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland
- (2009) Enrique Sánchez-Lemus et al. BRAIN BEHAVIOR AND IMMUNITY
- Crosstalk between peroxisome proliferator-activated receptor-γ and angiotensin II in renal tubular epithelial cells in IgA nephropathy
- (2009) Jing Xiao et al. CLINICAL IMMUNOLOGY
- PPARγ and its ligands: therapeutic implications in cardiovascular disease
- (2009) Luis Villacorta et al. CLINICAL SCIENCE
- PPARs: the vasculature, inflammation and hypertension
- (2009) Sheng Zhong Duan et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Inhibition of Tumor Necrosis Factor-α–Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer-Binding Protein-β
- (2009) Qingping Tian et al. HYPERTENSION
- Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
- (2009) Kana Tsukuda et al. HYPERTENSION
- Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes
- (2009) Ignacio M Larrayoz et al. JOURNAL OF HYPERTENSION
- PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway
- (2009) Yuanyuan Ji et al. LABORATORY INVESTIGATION
- Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
- (2009) Marvin A Konstam et al. LANCET
- A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells
- (2008) Adriana Lombardi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality
- (2008) Panagiotis C. Stafylas et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
- (2008) Bin Xing et al. Journal of Neuroinflammation
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started